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The assertion by the Health Professions 
Council of South Africa (HPCSA) that 
ethical tariffs ‘will be scrapped’ and 
replaced by a new National Health 
Reference Price List (NHRPL) by the 
end of April or May is ‘premature, 
unilateral and uninformed – not to 
mention impractical’.
These are the combined views of 
Trevor Terblanche, Chairperson of the 
General Practitioners Private Practice 
Committee (GPPPC), and his Specialist 
Private Practice Committee (SPPC) 
counterpart, Mzukisi Grootboom.
The move, if implemented, would 
effectively seal the vice grip the funding 
industry has established over doctors, 
and replace the ‘willing buyer, willing 
seller’ principle  with an arbitrary rock-
bottom pricing benchmark.
Studies conducted by independent 
health care consultancy, HealthMan, 
indicate that the current NHRPL tariffs 
will have to increase by at least 170% for 
procedures and by 120% for specialist 
consulting codes to reflect the cost of 
running a private practice. For GPs a 
further increase of at least 25% will be 
required. The results of these studies (of 
1 296 specialist and GP practices) were 
presented to the DoH on 20 May last 
year and were ‘consistent’ with SAMA 
submissions exactly a year earlier. Both 
claim to show that the HPCSA erred in 
not adjusting the HPCSA ethical tariffs 
in 2007 and 2008.
Terblanche said that for the HPCSA 
to replace the ethical tariff (three times 
the NHRPL) with the NHRPL when the 
benchmark Reference Price List (RPL) 
had yet to be finalised (verification of 
the cost studies still underway) ‘simply 
boggles the mind’.
Grootboom said the DoH itself 
acknowledged that the 2004-published 
RPL was ‘illegal’ and had agreed to a 
process of verifying the highly detailed 
and expensive South African Medical 
Association (SAMA) cost studies.
‘premature’
Terblanche said this would take ‘at 
least another 2 - 3 months’ before being 
subject to a process of publication 
and comment (he was speaking on 
30 January). Grootboom said that the 
HPCSA, ‘bowing to pressure from the 
DoH and funders’, had already decided 
in December last year to scrap the 
ethical rate and was now seemingly 
hell-bent on a PR exercise to legitimise 
its intentions. 
The duo were reacting to HPCSA 
Registrar Advocate Boyce Mkhize’s 
press conference at the end of January 
in which he outlined intended tariff 
principles, re-asserted the HPCSA’s 
intentions and set a time line, claiming 
‘industry-wide consultations’.
Mkhize indicated there would be 
more consultations before the arbitrary 
new deadline and was at pains to 
emphasise that scrapping the ethical 
tariffs was ‘in no way a means to short-
change practitioners’.
Terblanche said Mkhize’s press 
conference was ‘merely restating their 
position of last November, in fact pre-
empting the discussion that should 
rightly be held at the Medical and 
Dental Professions Board (MDPB), 
and after the new HPCSA board is 
constituted’.
Mkhize said that in terms of Section 
53 of the Health Professions Act of 
1974, the HPCSA, as a regulatory body,  
would retain its authority to determine 
whether a practitioner had overcharged 
a patient or not. 
hpcsA’s billing ‘guiding 
principles’
In reaching this ‘determination’, the 
HPCSA would use a number of ‘guiding 
principles’. These were that:
•    A practitioner should charge a 
non-insured patient the NHRPL 
rate, except where the patient 
provided written informed consent 
for a billing higher than this rate. 
Any charge above the NHRPL 
rate without a patient’s written 
consent would be deemed to be 
overcharging. 
•    A practitioner could also charge a 
private-paying insured patient a 
rate payable by the patient's medical 
scheme if the rate was higher than 
the NHRPL rate. However, any rate 
higher than the relevant medical 
scheme rate would be deemed to 
be overcharging, except where the 
patient had given written informed 
consent. 
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•    For the purposes of establishing 
whether the patient had provided 
informed consent, the practitioner 
‘must tell the patient the prevailing 
NHRPL or medical scheme rate 
for whatever procedure the patient 
presents for,’ said Mkhize. 
The practitioner would also need to 
indicate the difference between the rates 
as well as the amount the patient may 
have to pay in addition to the stipulated 
rate. Both doctor group spokespersons 
denied that they were properly 
consulted on what Mkhize was now 
presenting as a ‘virtual fait accompli’.
Ignoring history endangers 
health care delivery
Both said the HPCSA was also ignoring 
the history of medical aid fee structures 
that led to the DoH (in spite of agreeing 
that an RPL should reflect the basic cost 
of rendering a service) entrenching BHF 
rates as an RPL in 2004.
Grootboom said that in the 1970s 
and 80s, when medical aids were 
first introduced, SAMA agreed with 
funders that they would charge a lower 
fee – provided they were guaranteed 
payment after rendering the service. 
This enabled medical aids to garner 
more members at more affordable rates 
and gave doctors an assured income. 
Doctors’ fees were negotiated annually 
and then gazetted. However, in a 
seismic shift, the section of the Medical 
Schemes Act guaranteeing payment 
was removed, ‘pulling the ground’ 
from under doctors and leaving an 
ever-widening gap between the medical 
aid fee and the costs of rendering the 
service.
To aggravate matters there was 
no tariff increase that year and, until 
2008, only ‘below inflation’ annual 
increases, making the proposed NHRPL 
tariff ridiculously low, especially for 
specialists requiring high overheads to 
retain professional standards.
Grootboom emphasised: ‘In our view 
even the so-called ethical fee does not 
reflect the cost incurred by providers.’ 
He said ethical tariffs were bedevilled 
by the very use of the word ‘ethical’ 
given the varying costs between 
different practices and their locations.
Terblanche illustrated the difficulties 
created in the public mind via the 
tariff nomenclature used to describe 
the preferred ‘ethical’ cost ceiling:  ‘It 
implies that if you exceed it you are 
being unethical … in other words you 
are criminalising the behaviour of 
thousands of doctors, who according to 
the Competitions Commission and our 
national Constitution, have a right to set 
their own fees’.
Mkhize appeared not to understand 
the essence of what the RPL 
represented, i.e. that it was merely one 
of several benchmarks. Doctors had an 
ethical duty to look at the circumstances 
of every patient and hence to arrive at ‘a 
mutual value exchange’.
Grootboom said his group 
acknowledged that there had to be 
‘some sort of guideline’, but putting 
a ceiling on prices while substantive 
differences in demographics and 
geography existed gave rise to ‘all sorts 
of anomalies’.
The SPPC encouraged an active 
role in the peer review committees 
of various specialist groups in 
determining whether a fee amounted to 
overcharging or not.
It agreed with the HPCSA that 
doctors should discuss their fees and 
costs with patients, who must agree 
to the fee prior to the service being 
rendered.  ‘For example, in a hip 
replacement, support the patient to 
contact the anaesthetist to get his costs, 
phone the medical aid, see what they 
cover and then get them to come back 
to you and see how much they can 
afford – they must be happy before 
you go ahead.’ This would drastically 
reduce the number of disgruntled 
patients writing to the HPCSA about 
‘overcharging’.
Grootboom accused Mkhize of ‘trying 
to legitimise an illegal process’.
hpcsA interfering with ‘free 
economic activity’
Terblanche said the HPCSA was 
‘overstepping its mandate’ (to ‘protect 
the public, consumers of health care 
services and provide guidance on 
educational, professional and ethical 
issues to practitioners’) by determining 
what fees a doctor should charge.
The HPCSA should stick to its job 
of determining what ethical behaviour 
was, ‘not what you’re charging’.
He qualified this by adding: ‘I 
understand that we’ve been sitting 
with a situation where some of our 
profession used the pricing model to 
perhaps charge what many regard as a 
very high fee. But that doesn’t make it 
unethical.’ He said that policing wilfully 
incorrect billing or abuse of codes 
was more appropriate to the HPCSA’s 
mandate. SAMA was ‘quite willing’ to 
play the role of peer facilitator when 
it came to inappropriate and incorrect 
billing and to help with advice through 
its specialist and GP groups.
Asked what would happen if the 
new tariffs were forced through, 
Terblanche said the profession needed 
to ‘be clear in terms of what its rights 
are’, so it could ‘examine its options’, 
but he stopped short of threatening 
court action. The mere fact that the 
HPCSA had admitted it did not have 
the capacity to come up with an ethical 
price list by itself begged the question of 
how it would enforce new regulations 
‘when myriads of complaints start to 
come in about overcharging’. South 
Africa had ‘bigger issues to deal with 
than this – we must get together and 
make a decision that makes the most 
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sense for as many South Africans as 
possible,’ he said.
Former SAMA chairman, Kgosi 
Letlape, cited his frustrations at 
attempting to lobby for a more 
equitable health dispensation (relying 
on a universal health tax instead of 
‘iniquitous’ medical aids), as a primary 
reason for resigning in January.
The latest HPCSA move follows 
last year’s draft bill proposing an 
amendment to the National Health Act, 
creating a national ‘facilitator’ for health 
pricing, a tribunal to make rulings and 
‘inspectors’ with draconian data search 
and seizure powers.
A survey found that if passed, this bill 
would have ‘far-reaching and possibly 
fatal impact on private practice, 
compromising the ability of the health 
department to progressively increase 
access to health care for all South 
Africans’. 
chris Bateman
The HPCSA should stick to 
its job of determining what 
ethical behaviour was, ‘not 
what you’re charging’.
Calling all McCordites, 
friends, ex-staff, ex-interns …
McCord Hospital is 100
We would be honoured if you could join us at 
McCord Hospital in May this year to celebrate 
this once in a lifetime event with us.
Events Schedule:
Friday 1 May    Mayoral Civic Reception
Saturday 2 May    Centennial Presentations at the Durban        
                                City Hall, 9h00 - 13h00
                                Tours of the Hospital, 14h00 - 17h00
Sunday 3 May    Thanksgiving Service, 10h30 - 13h00
Please contact us for further information 
or to book a place. 
Dr Helga Holst, CEO 
E-mail:  info@mccord.co.za
Fax: +27 (0)86 519 3297
